Skip to content

Removal of fibromata pendulantia: scissor excision vs. 532 nm-laser

Removal of fibromata pendulantia: scissor excision vs. 532 nm-laser - FibLas

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00024552
Enrollment
68
Registered
2021-03-04
Start date
2021-04-22
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D23.9

Interventions

Group 1: excision by scissors We will use both treatment methods on each subject. We will always start with the left side of the body (neck or armpits). The randomised allocation of which procedure w

Sponsors

Praxis Prof. Dr. Krengel/Dr. Mrowka/Dr. Haase
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The clinical diagnosis is clearly fibromata pendulantia. 2. The patient is at least 18 years old. 3. The patient should be under sixty so that no high-risk patients have to be called into the doctor's office in times of the COVID-19 pandemic. 4. The patient is able to understand and sign the patient information sheet and informed consent form. 5. The patient is able to follow all study instructions and attend all study appointments. 6. The patient is not pregnant and does not breastfeed. 7. The patient is in good general health and is free from disease or physical complaints, e.g. other skin diseases, which, in the opinion of the investigator, might interfere with the evaluation of a target lesion or would expose the subject to unacceptable risk by participating in the study.

Exclusion criteria

Exclusion criteria: 1. The patient is pregnant and/or breastfeeding. 2. The patient is younger than 18 and older than 59 years. 3. The patient has mental retardation, dementia and/or requires a legal guardian. 4. The patient is not willing to abstain from unprotected sunbathing or tanning. 5. The patient has a flurid or uncontrolled skin condition in the study area (e.g. psoriasis, eczema, or a skin condition (sunburn) that, in the opinion of the investigator, would endanger the patient if he/she participated in the study or could interfere with the study procedure. 6. Severe coagulation disorders; ASA and Marcumar use are not exclusion criteria, Factor Xa antagonists can be paused 24 h before treatment.

Design outcomes

Primary

MeasureTime frame
Hypothesis: Treatment by the 532 nm LBO laser shows the highest acceptance among the subjects ("Which procedure would you prefer if you were treated again?").

Secondary

MeasureTime frame
1. The treatment with scissors is more painful than the treatment with the LBO laser. 2. The subjects find it an advantage that there is no bleeding with laser therapy and no bandages are needed. 3. The laser therapy causes less pigment displacement and scars. The cosmetic result is objectively better after 3 months.

Countries

Germany

Contacts

Public ContactCharlotte Winkelmann-Schirmer

Hautpartner

winkelmann-schirmer@hautpartner.de0451-78929480

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026